Zdrowie i gospodarka · 02/04/2019
FDA Proposes to Revise Mycoplasma Test for Live and Inactivated Virus Vaccines
The FDA is proposing to remove a specific test for Mycoplasma from its biologics regulations, allowing for more flexible testing methods and accommodating new technologies while maintaining public health protections.
Source: Federal Register — Food and Drug AdministrationOpen original release →